Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 175 (ZNF175, also known as OTK18) is a transcription factor containing 13 contiguous C2H2-type zinc finger motifs, encoded by the ZNF175 gene on human chromosome 19[5]. It is primarily located in the cytosol and nucleolus[2]. ZNF175 functions as a transcriptional regulator—repressing and activating RNA polymerase II-mediated transcription of specific gene sets. It down-regulates chemokine receptor expression and can inhibit HIV-1 replication by suppressing Tat-dependent transcription of the viral LTR promoter, suggesting a functional role in innate immune regulation[2][6]. Diseases associated with ZNF175 include various forms of non-syndromic X-linked intellectual disability, and its upregulation in macrophages upon HIV infection has been described, indicating significance in infection biology and immune responses[1][2].
Not established; current mechanistic insights relate to transcriptional suppression of viral genes and chemokine receptor regulation rather than established drug mechanisms
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 175 (ZNF175).